The AI safety net for maternal hypertension.
A six-agent AI platform on IBM watsonx Orchestrate that detects and escalates hypertension risk across the third trimester and postpartum window - closing the gap that causes 70% of maternal hypertension deaths.
Between obstetric visits, no clinician is watching.
Hypertensive disorders complicate 1 in 10 U.S. pregnancies. The clinical calendar stops watching after discharge - but the risk doesn't.
Pregnancies affected
U.S. pregnancies complicated by a hypertensive disorder - preeclampsia, gestational hypertension, or chronic hypertension.
Deaths occur post-discharge
Maternal hypertension deaths happen after the patient leaves the hospital - in the gap between visits where no one is monitoring.
Classified as preventable
The CDC classifies 80% of these deaths as preventable. The gap is not clinical knowledge - it is continuous monitoring between visits.
Annual U.S. market
The total addressable market for maternal hypertension monitoring in the United States alone.
One transparent risk verdict.
Coordinated by a central Supervisor on IBM watsonx Orchestrate, six purpose-built agents work in parallel - from signal intake to patient communication in under 25 seconds.
Signal Intake
Ingests BP readings, symptom SMS, EHR history, and gestational age from four parallel streams.
Risk Surveillance
Evaluates every BP reading against patient baseline and ACOG thresholds with postpartum auto-elevation.
Symptom Triage
Parses patient symptom reports using NLU - headache, vision changes, epigastric pain - extracting structured clinical entities.
Gestational Context
Applies correct ACOG thresholds based on gestational stage - differentiating third-trimester from postpartum risk.
Clinical Escalation
Pages the on-call OB via Microsoft Teams within seconds and automatically books a telehealth appointment.
Care Navigator
Sends the patient a plain-language SMS immediately after escalation with clear next steps.
Designed for the moments that matter most.
Dual-window coverage
Monitors both the third trimester and postpartum period from a single platform with stage-aware ACOG thresholds applied at each window.
Under 25 seconds
From a blood pressure reading to a safe, documented clinical action in under 25 seconds - with zero manual triage required.
Compliant by architecture
End-to-end encryption, signed BAAs, FDA Class II SaMD pathway, Health Canada parallel filing, and continuous AI governance.
Proven, preventable impact
80% of maternal hypertension deaths are preventable. 70% occur post-discharge. Vital Sense closes that gap at scale.
Seamless integrations.
Designed for clinical procurement from day one.
FDA SaMD Class II
Architected for 510(k) submission with a predicate device cohort already identified.
Health Canada SaMD Class II
Parallel U.S. and Canadian regulatory pathways for dual-market entry without compliance duplication.
HIPAA and PIPEDA compliant
End-to-end encryption, signed BAAs with all subprocessors, and regional data residency as standard.
Continuous AI governance
Model lineage, drift detection, and bias monitoring via IBM watsonx.governance - audit-ready by default.
See Vital Sense in action.
From blood pressure reading to documented clinical action in under 25 seconds. Connect with our team for a walkthrough.